Mirjam Boelens to Drug Resistance, Neoplasm
This is a "connection" page, showing publications Mirjam Boelens has written about Drug Resistance, Neoplasm.
Connection Strength
0.244
-
Mutational profiles associated with resistance in patients with BRAFV600E mutant colorectal cancer treated with cetuximab and encorafenib +/- binimetinib or alpelisib. Br J Cancer. 2021 01; 124(1):176-182.
Score: 0.147
-
Exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways. Cell. 2014 Oct 23; 159(3):499-513.
Score: 0.097